Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, MiRNA-based therapy for Myocardial infarction: Sox2 protects against ischemia/reperfusion injury and promotes cardiomyocyte survival via up regulation of pro-survivval protein Bcl-2, 2/April/2015, 13.40, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: Sox2, by increasing the expression of its target gene, it may increase the expression of pro-survival protein Bcl-2. Thereby, it may inhibit myocardial apoptosis. Thus, pharmacological formulations encompassing “Sox2 activators” may be used to treat myocardial infarction.
Courtesy: When you cite drop us a line at firstname.lastname@example.org
* Research cooperation
Undisclosed information: How Sox2 increases the expression of Bcl-2